RAD140 vs LGD4033: Research Comparison

Selective androgen receptor modulators, commonly called SARMs, are synthetic compounds studied for their ability to selectively activate androgen receptors in muscle and bone tissue. Researchers investigate these compounds because they may promote muscle growth and improve lean body mass while interacting differently with other tissues compared with traditional anabolic steroids.

Two of the most widely discussed SARMs in research literature are RAD140 (Testolone) and LGD-4033 (Ligandrol). Both compounds interact with androgen receptors and are commonly studied in relation to skeletal muscle biology, bone density research, and hormonal signalling pathways.

This RAD140 vs LGD4033 research comparison explores how these two selective androgen receptor modulators differ in receptor activity, muscle research findings, pharmacokinetics, and scientific interest.

What Are Selective Androgen Receptor Modulators

Selective androgen receptor modulators are synthetic compounds designed to bind to androgen receptors and activate anabolic signalling in specific tissues.

Androgen receptors are proteins found in many tissues of the body, particularly skeletal muscle and bone. When activated, these receptors trigger biological processes related to protein synthesis, muscle growth, and bone density.

Traditional anabolic androgenic steroids stimulate androgen receptors across many tissues, which can lead to widespread hormonal effects. SARMs aim to achieve selective androgen receptor modulation, meaning they preferentially stimulate muscle and bone tissue while minimizing activity in other areas.

Researchers study SARMs to better understand:

• skeletal muscle growth pathways
• lean body mass regulation
• androgen receptor signalling
• bone density mechanisms

For deeper background, see What Are Androgen Receptors and Understanding the Mechanism of Action of SARMs.

Overview of RAD140 (Testolone)

What Is RAD140

RAD140, also known as Testolone, is a selective androgen receptor modulator with very strong binding affinity to androgen receptors in skeletal muscle and bone.

Preclinical research indicates that RAD140 activates anabolic signalling pathways associated with protein synthesis and muscle hypertrophy. Because of its high receptor affinity, RAD140 is often described as one of the most potent SARMs studied in muscle research.

Studies have also explored RAD140 for potential neuroprotective properties. Some research suggests it may influence neurological pathways that protect neurons from degeneration.

Areas of scientific interest surrounding RAD140 include:

• skeletal muscle growth
• androgen receptor signalling
• anabolic activity in muscle tissue
• potential neuroprotective pathways

More detailed discussion can be found in the RAD140 guide.

Overview of LGD4033 (Ligandrol)

What Is LGD4033

LGD4033, commonly called Ligandrol, is another selective androgen receptor modulator studied for its ability to increase lean body mass and support skeletal muscle growth.

LGD4033 binds selectively to androgen receptors in skeletal muscle and bone tissue. Clinical studies involving healthy young men have demonstrated significant improvements in lean body mass when exposed to LGD4033 in controlled research settings.

Because of its predictable and controlled anabolic signalling, LGD4033 has been studied in research exploring muscle wasting conditions and bone density regulation.

Scientific interest in LGD4033 focuses on:

• lean body mass development
• skeletal muscle signalling
• bone density research
• anabolic hormone pathways

More background is available in the LGD4033 guide.

RAD140 vs LGD4033 Comparison Table

Feature	RAD140 (Testolone)	LGD4033 (Ligandrol)
Compound Type	Selective androgen receptor modulator	Selective androgen receptor modulator
Primary Research Focus	Muscle hypertrophy and androgen receptor signalling	Lean body mass and bone density research
Receptor Affinity	Very high androgen receptor binding	High but slightly lower receptor affinity
Muscle Growth Research	Rapid anabolic signalling and hypertrophy	Controlled lean muscle mass development
Half Life	Approximately 45–60 hours	Approximately 24–36 hours
Research Potency	Considered highly potent in research models	Moderate but predictable anabolic activity
Additional Research Interest	Neuroprotective pathways and breast cancer research	Muscle wasting and bone density studies

Muscle Tissue Research

Both RAD140 and LGD4033 have been studied for their effects on skeletal muscle growth and lean body mass.

RAD140 research suggests powerful anabolic signalling that increases muscle protein synthesis and promotes muscle hypertrophy. Because of its potency, RAD140 often produces rapid increases in lean muscle mass in experimental models.

LGD4033 tends to produce slower but highly controlled improvements in lean mass. Clinical trials have shown measurable improvements in lean body mass among healthy young men exposed to LGD4033.

Both compounds activate androgen receptors in skeletal muscle, triggering biological pathways involved in muscle growth and physical function.

Bone Density Research

Researchers are also exploring SARMs for their potential influence on bone health.

LGD4033 binds strongly to androgen receptors in bone tissue and has been studied for possible applications related to bone density and skeletal strength.

RAD140 has also demonstrated anabolic activity in bone tissue in preclinical models, suggesting potential relevance for skeletal research.

Research Potency and Selectivity

RAD140 is widely considered one of the most potent SARMs due to its extremely strong receptor binding affinity. This high affinity leads to powerful anabolic signalling in skeletal muscle.

LGD4033 demonstrates slightly lower potency but provides predictable and controlled anabolic activity. Because of this balance, LGD4033 is often studied in controlled clinical research involving lean mass development.

Neuroprotective Research Interest

One unique aspect of RAD140 research involves potential neuroprotective effects.

Preclinical studies have explored whether RAD140 may help protect neurons from degeneration and oxidative stress. This has sparked interest in neurological research applications beyond muscle biology.

LGD4033 has not shown the same level of neuroprotective research focus.

Similarities Between RAD140 and LGD4033

Despite their differences, RAD140 and LGD4033 share several key characteristics.

Both compounds:

• belong to the class of selective androgen receptor modulators
• bind to androgen receptors in skeletal muscle and bone
• promote anabolic signalling and protein synthesis
• support lean body mass development in research models
• do not convert into estrogen or dihydrotestosterone

Both compounds are also included on the World Anti-Doping Agency prohibited list, meaning they are banned in competitive sports.

Limitations of Current Research

Although RAD140 and LGD4033 have been studied in laboratory and early clinical research, long-term scientific data is still developing.

Many studies involve controlled research environments, and additional clinical trials are needed to better understand the full biological mechanisms and potential applications of these compounds.

Future Research Directions

Researchers continue to explore selective androgen receptor modulators in several emerging areas of scientific interest, including:

• muscle loss associated with aging
• metabolic disorders affecting lean mass
• bone density research
• hormonal signalling pathways

Understanding how androgen receptor modulation influences muscle biology and metabolic health remains an active area of scientific investigation.

Conclusion

RAD140 and LGD4033 represent two of the most studied selective androgen receptor modulators in modern androgen receptor research.

RAD140 demonstrates strong anabolic signalling and potential neuroprotective properties, while LGD4033 provides controlled increases in lean body mass with supporting clinical research.

Both compounds continue to attract scientific interest in studies exploring muscle biology, bone density, and androgen receptor signalling.

FAQs

What is the difference between RAD140 and LGD4033 in research

RAD140 generally demonstrates stronger receptor affinity and faster anabolic signalling, while LGD4033 produces slower but controlled increases in lean body mass.

Which SARM has stronger receptor affinity

RAD140 is widely considered to have stronger androgen receptor binding affinity compared with LGD4033.

Are RAD140 and LGD4033 studied for muscle tissue research

Yes. Both SARMs are studied for their effects on skeletal muscle growth, protein synthesis, and lean body mass development.

Why are SARMs studied in laboratory environments

Researchers study SARMs to understand how selective androgen receptor activation influences muscle biology, bone density, and hormonal signalling pathways.